AUG 17, 2020 12:22 AM PDT

Therapy Found in The Shell of Cashews

WRITTEN BY: Nouran Amin

A compound found in the shell of cashews can help in neurodegeneration.

"We see this as an exciting finding, suggesting a new avenue in the search for therapies to correct the ravages of MS and other demyelinating diseases," said the paper's senior author, Subramaniam Sriram, MBBS, William C. Weaver III Professor of Neurology and chief of the Division of Neuroimmunology.

The compound can repair myelin sheath, a protective insulating material of the nervous system. Damage to the myelin sheath results in diseases of the central nervous system, one being multiple sclerosis.

Learn more:

Findings were reported by a team from Vanderbilt University Medical Center and published in the Proceedings of the National Academy of Sciences. The results describe work on demyelinated animal models who were treated with anarcardic acid in a dose-dependent manner.

"These are striking results that clearly urge further study of anarcardic acid for demyelinating diseases," Sriram said.

Source: Science Daily

About the Author
BS/MS
Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
JUL 20, 2022
Neuroscience
Stress Transmitter Wakes Up the Sleeping Brain Over 100 Times Per Night
JUL 20, 2022
Stress Transmitter Wakes Up the Sleeping Brain Over 100 Times Per Night
A study published in Nature Neuroscience reported that the stress hormone and transmitter noradrenaline wakes up the hum ...
JUL 23, 2022
Drug Discovery & Development
Anti-inflammatory Compound Shows Promise in Treating Severe COVID-19
JUL 23, 2022
Anti-inflammatory Compound Shows Promise in Treating Severe COVID-19
An anti-inflammatory compound has shown promise in treating systemic inflammation and brain injury in patients with seve ...
AUG 11, 2022
Clinical & Molecular DX
New Tuberculosis Vaccine Enters Phase III Clinical Trial
AUG 11, 2022
New Tuberculosis Vaccine Enters Phase III Clinical Trial
Tuberculosis is a disease caused by the bacterium Mycobacterium tuberculosis. It is spread through the air when a person ...
AUG 11, 2022
Drug Discovery & Development
Alzheimer's disease gets new drug without side effects
AUG 11, 2022
Alzheimer's disease gets new drug without side effects
In a recent study published in Nature Medicine, a team of researchers from the Korea Advanced Institute of Science and T ...
SEP 13, 2022
Immunology
How Cell 'Waste' Boosts Immune Cells' Fight Against Cancer
SEP 13, 2022
How Cell 'Waste' Boosts Immune Cells' Fight Against Cancer
It seems there is a lot more to lactate than we knew.
SEP 26, 2022
Immunology
A Rheumatoid Arthritis-Promoting Molecule is Identified
SEP 26, 2022
A Rheumatoid Arthritis-Promoting Molecule is Identified
Researchers have found that a protein called sulfatase-2 may play a significant role in the tissue damage caused by rheu ...
Loading Comments...